Bladder Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Aug 30, 2018
- Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.
Fabrizio David A et al. Journal of gastrointestinal oncology 2018 Aug 9(4) 610-617 - Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome.
Huang Dora et al. Bladder cancer (Amsterdam, Netherlands) 2018 Jul 4(3) 261-268 - A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Degener Stephan et al. Mini reviews in medicinal chemistry 2018 18(13) 1133-1142 - Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.
Vandekerkhove Gillian et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Nov 23(21) 6487-6497 - Molecularly-driven precision medicine for advanced bladder cancer.
Krabbe Laura-Maria et al. World journal of urology 2018 Jun - An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.
Soria Francesco et al. World journal of urology 2018 Jun - Mutation-counting blood test could predict if cutting-edge immunotherapies can beat a cancer
K Garber, Science, June 27, 2018 - Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
Tölle Angelika et al. Biomarkers in medicine 2018 Jun - MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.
Liu Hao et al. BMC cancer 2018 Jun 18(1) 659 - Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening.
Rinaldetti Sebastien et al. Oncotarget 2018 May 9(40) 25935-25945
.png)
No hay comentarios:
Publicar un comentario